Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis

Techniques in Coloproctology

Volumn 12, Issue 1, 2008, Pages 33-38

  Leal, R F ^a   Coy, C S R ^a   Ayrizono, M L S ^a   Fagundes, J J ^a   Milanski, M ^a   Saad, M J ^a   Velloso, L A ^a   Goes J R N ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Apoptosis; Cytokines; Familial adenomatous polyposis; Ileal pouch; Pouchitis; Ulcerative colitis

Indexed keywords

APOPTOSIS PROTEIN; CYTOKINE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN; PROTEIN BAD; TUMOR NECROSIS FACTOR ALPHA;

ADENOMATOUS POLYP; ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOSCOPY; FAMILIAL POLYPOSIS; FEMALE; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM MUCOSA; ILEUM POUCH; IMMUNOBLOTTING; INTESTINE BIOPSY; MALE; PELVIS; PROCTOCOLECTOMY; PROTEIN EXPRESSION; SURGICAL APPROACH; SURGICAL TECHNIQUE; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI; ADULT; ANALYSIS OF VARIANCE; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; COLITIS, ULCERATIVE; COLONIC POUCHES; CYTOKINES; FEMALE; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NF-KAPPA B; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44649101390     PISSN: 11236337     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10151-008-0395-9     Document Type: Article

References (51)

1. Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 2:85-87
2. Utsunomiya J, Iwama T, Imajo M et al (1980) Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum 23:459-466
3. Nicholls RJ, Moskovitz RL, Shepard NA (1985) Restorative proctocolectomy with ileal reservoir. Br J Surg 72:76-79
4. Nicholls RJ (1987) Restorative proctocolectomy with various types of reservoir. World J Surg 11:751-762
5. M'Koma AE (2006) Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis 26:1-10
6. Kiehne K, Brunke G, Wegner F et al (2006) Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 12:1056-1062
7. Heuschen UA, Allemeyer EH, Hinz U et al (2002) Diagnosing pouchitis: comparative validation of two scoring system in routine follow-up. Dis Colon Rectum 45:776-786
8. Shen B, Fazio VW, Remzi FH et al (2006) Risk factors for disease of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 4:81-89
9. Moskowitz RL, Shepard NA, Nicholls RJ (1986) An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1:167-174
10. Armstrong DN, Sillin LF, Chung R (1995) Reduction in tissue blood flow in J-shaped pelvic ileal reservoirs. Dis Colon Rectum 38:526-529
11. Laake KO, Bjorneklett A, Aamodt G et al (2005) Outcome of four weeks intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand J Gastroenterol 40:43-51
12. Ohge H, Furne JK, Springfield J et al (2005) Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 48:469-475
13. Kuehbacher T, Ott SJ, Helwig U et al (2006) Bacterial and fungal microbiota in relation to probiotic therapy in pouchitis. Gut 55:833-841
14. Sandborn WJ (1994) Pouchitis following ileal pouch anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 107:1856-1860
15. Nicholls RJ, Banerjee AK (1998) Pouchitis: risk factores, etiology, and treatment. World J Surg 22:347-356
16. Sandborn WJ, Tremaine WJ, Batts KP et al (1994) Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 69:409-415
17. Shen B, Achkar JP, Connor JT et al (2003) Modified pouchitis disease activity index. A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 46:748-753
18. Akerlung JE, Lofberg R (2004) Pouchitis. Curr Opin Gastroenterol 20:341-344
19. Lohmuller JL, Pemberton JH, Dozois RR et al (1990) Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 211:622-629
20. Hata K, Watanabe T, Shinozaki M et al (2003) Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 38:1055-1058
21. O'shea J, Ma A, Lipsky P (2002) Cytokines and autoimmunity. Nature Rev 2:37-45
22. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edge sword. Nature Rev 3:745-756
23. Pullman WE, Elsbury S, Kobayashi M et al (1992) Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102:529-537
24. Raab Y, Gerdin B, Ahlstedt S et al (1993) Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34:1203-1206
25. Nielsen OH, Brynskov J, Bendizen K (1993) Circulating and mucosal concentrations of tumor necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Dan Med Bull 40:247-249
26. Gionchetti P, Campieri M, Belluzzi A et al (1994) Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci 39:1525-1531
27. Patel RT, Bain I, Youngs D et al (1995) Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 38:831-837
28. Evgenikos N, Bartolo DCC, Hamer-Hodges DW et al (2002) Assessment of ileoanal pouch inflammation by interleukin 1β and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 45:249-255
29. Balzano A, Bevilacqua N, Nappo C et al (1998) Cytokines and ulcerative colitis: mucosal balance between pro and anti-inflamatory cytokines in patients with and without pouchitis. Gastroenterology 114:A925
30. Bulois P, Tremaine WJ, Maunoury V et al (2000) Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 6:157-167
31. Lammers KM, Vergopoulos A, Babel N et al (2005) Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1β, interleukin-8 and interferon-γ gene expression. Inflamm Bowel Dis 11:447-454
32. Coffey JC, Bennett MW, Wang JH et al (2001) Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis-a putative role in pouchitis? J Surg Res 98:27-32
33. Chen LF, Greene WC (2004) Shaping the nuclear action of NFkB. Nature Rev 5:392-401
34. Góes JRN, Fagundes JJ, Coy CSR et al (1994) Preservation of the vascular arcade of the right colon to the mesentery lenghtening in the ileal pouch procedure. Rev Bras Coloproct 14:169-171
35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
36. Velloso LA, Folli F, Sun XJ et al (1996) Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93:12490-12495
37. Araújo EP, De Souza CT, Gasparetti AL et al (2005) Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistence, hyperinsulinemia, and increased adiposity. Endocrinology 146:1428-1437
38. Kuhbacher T, Schreiber S, Runkel N (1998) Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 13:196-207
39. Tulchinsky H, Hawley PR, Nicholls J (2003) Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 238:229-234
40. Reinecker HC, Steffen M, Witthoeft T et al (1993) Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patient with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181
41. Wehkamp J, Schwind B, Herrlinger KR et al (2002) Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci 47:1349-1355
42. Wehkamp J, Harder J, Weichenthal M et al (2003) Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 9:215-223
43. Sadouk MB, Pelletier JP, Tardif G et al (1995) Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab. Invest 73:347-355
44. Sandborg CI, Imfeld KL, Zaldivar F Jr et al (1995) IL-4 expression in human T cells is selectively inhibited by IL-1α and IL-1β. J Immunol 155:5206-5212
45. Colditz I, Zwahlen R, Dewald B et al (1989) In vivo inflammatory activity of neutrophil activating factor, a novel chemotactic peptide derivated from human monocytes. Am J Pathol 134:755-760
46. Schoeder J, Christophers E (1989) Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 142:244-251
47. Gross A, McDonnell JM, Korsmeyer SJ (1999) Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911
48. Kuwana T, Newmeyer DD (2003) Bcl-2 family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15:691-699
49. Vermeulen K, Van Bockstaele DR, Bernemann ZN (2005) Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84:627-639
50. Widmann C, Gibson S, Johnson GL (1998) Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273:7141-7147
51. Festjens N, Van Gurp M, Van Loo G et al (2004) Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 111:7-27